AEGISVOPAK - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.8
| Stock Code | AEGISVOPAK | Market Cap | 19,515 Cr. | Current Price | 176 ₹ | High / Low | 302 ₹ |
| Stock P/E | 110 | Book Value | 42.2 ₹ | Dividend Yield | 0.00 % | ROCE | 6.53 % |
| ROE | 7.70 % | Face Value | 10.0 ₹ | DMA 50 | 215 ₹ | DMA 200 | 238 ₹ |
| Chg in FII Hold | -0.04 % | Chg in DII Hold | -0.05 % | PAT Qtr | 51.1 Cr. | PAT Prev Qtr | 49.0 Cr. |
| RSI | 31.2 | MACD | -9.85 | Volume | 8,56,663 | Avg Vol 1Wk | 5,58,779 |
| Low price | 172 ₹ | High price | 302 ₹ | PEG Ratio | 0.30 | Debt to equity | 0.40 |
| 52w Index | 3.51 % | Qtr Profit Var | 50.3 % | EPS | 1.65 ₹ | Industry PE | 51.0 |
📊 Analysis: AEGISVOPAK shows weak fundamentals for long-term investment. ROE at 7.7% and ROCE at 6.53% are below desirable levels, indicating inefficient capital use. The P/E ratio of 110 is extremely high compared to the industry average of 51, suggesting severe overvaluation. Dividend yield is nil, reducing attractiveness for income investors. Debt-to-equity at 0.40 is manageable but higher than peers. Technical indicators (RSI 31.2, MACD negative, price below DMA 50 & 200) confirm bearish momentum. Despite quarterly profit growth, overall valuations and weak returns make this stock unattractive for long-term holding unless fundamentals improve.
💰 Ideal Entry Zone: ₹160 – ₹175, only for speculative accumulation if earnings growth sustains. Otherwise, avoid fresh entry until valuations normalize.
📈 Exit / Holding Strategy: Existing holders should consider exiting on any rebound toward ₹215–₹240 (near DMA levels). Long-term holding is not recommended unless ROE/ROCE improve significantly. Investors should reassess after 2–3 quarters of consistent earnings growth.
Positive
- Quarterly PAT growth (₹51.1 Cr vs ₹49 Cr) shows incremental improvement.
- PEG ratio of 0.30 indicates potential undervaluation if growth sustains.
- EPS of ₹1.65 reflects earnings visibility, though still modest.
Limitation
- Extremely high P/E (110) compared to industry average (51).
- Weak ROE (7.7%) and ROCE (6.53%) highlight poor capital efficiency.
- No dividend yield, reducing attractiveness for income investors.
- Stock trading below DMA 50 & 200 confirms weak technical trend.
Company Negative News
- Sharp correction from ₹302 to ₹176 shows investor caution.
- FII (-0.04%) and DII (-0.05%) holdings decreased, signaling reduced institutional confidence.
Company Positive News
- Quarterly profit variance at 50.3% highlights operational improvement.
- Stable PAT growth quarter-on-quarter indicates resilience.
Industry
- Industry P/E at 51 is significantly lower than company’s P/E (110), suggesting peers may offer better value.
- Logistics and storage sector growth supported by infrastructure expansion, but competition remains high.
Conclusion
⚖️ AEGISVOPAK is currently overvalued with weak return metrics, making it unsuitable for long-term investment. Entry should be avoided unless price corrects to ₹160–₹175 and fundamentals improve. Existing holders should consider exiting near ₹215–₹240. The company shows some profit growth, but low ROE/ROCE and high valuations pose significant risks for long-term investors.